secwatch.observer — SEC 8-K summary
======================================

Issuer:     Statera Biopharma, Inc. (—)
CIK:        0001318641
Form:       8-K
Filed at:   2023-01-20T23:59:59+00:00
Accession:  0001437749-23-001440
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Statera Biopharma delisted from Nasdaq; trades OTC Pink under STAB
------------------------------------------------------------------

- Received Nasdaq delisting notice Jan 10, 2023; trading suspended Jan 12, 2023.
- Company intends to appeal to Nasdaq Listing and Hearing Review Council.
- Stock now quoted on OTC Pink (STAB); applied for OTCQB listing with no assurance.
- Nasdaq had granted continued listing subject to $1 bid and $2.5M equity by Jan 31, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1318641/000143774923001440/0001437749-23-001440-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1318641/000143774923001440/cbli20230120_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-001440

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer